John Paulson Viatris Inc Transaction History

Paulson & Co. Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $12.8 Million - $15.5 Million	-1,055,079 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $30.3 Million - $34.6 Million	-2,289,391 Reduced 68.45%	1,055,079 $14.3 Million
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $105 Million - $131 Million	-8,133,790 Reduced 70.86%	3,344,470 $47.8 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $164 Million - $215 Million	11,478,260 New	11,478,260 $215 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Paulson & Co. Inc., based on Form 13F filings with the SEC.

Stay updated on Paulson & Co. Inc. and John Paulson with notifications on news.